Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of α‐synuclein in the substantia nigra
- 21 July 2005
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 19 (12) , 1740-1742
- https://doi.org/10.1096/fj.05-3845fje
Abstract
The neurotrophins brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) have been shown to promote survival and differentiation of midbrain dopaminergic (DAergic) neurons in vitro and in vivo. This is consistent with their expression and that of their cognate receptors, trkB and trkC, in the nigrostriatal system. Degeneration of DAergic neurons of the substantia nigra and alpha-synuclein-positive aggregates in the remaining substantia nigra (SN) neurons are hallmarks of Parkinson's disease (PD). Reduced expression of BDNF has been reported in the SN from PD patients. Moreover, mutations in the BDNF gene have been found to play a role in the development of familial PD. We show now that haploinsufficiencies of the neurotrophin receptors trkB and/or trkC cause a reduction in numbers of SN neurons in aged (21-23 month old) mice, which is accompanied by a reduced density in striatal tyrosine hydroxylase immunoreactive (TH-ir) fibers. These aged mutant mice, in contrast to wild-type littermates, display an accumulation of alpha-synuclein in the remaining TH-positive neurons of the SN. We conclude that impairment in trkB and/or trkC signaling induces a phenotype in the aged SN, which includes two hallmarks of PD, losses of TH positive neurons and axons along with massive neuronal deposits of alpha-synuclein.Keywords
Funding Information
- California Department of Fish and Game (302/TP A1, SFB 636/A5)
This publication has 40 references indexed in Scilit:
- Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia NigraExperimental Neurology, 2000
- Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transferPublished by Elsevier ,2000
- Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's diseasePublished by Elsevier ,1999
- Medial nigral dopamine neurons have rich neurotrophin support in humansNeuroReport, 1998
- Age-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: a comparison to those of nerve growth factor and neurotrophin-3Neuroscience Research, 1998
- Neurotrophins Prevent Death and Differentially Affect Tyrosine Hydroxylase of Adult Rat Nigrostriatal Neuronsin VivoExperimental Neurology, 1998
- Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degenerationCell Transplantation, 1996
- Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's diseaseJournal of Neuroscience, 1995
- In Situ Hybridization of trkB and trkC Receptor mRNA in Rat Forebrain and Association with High‐affinity Binding of [125I]BDNF, [125I]NT‐4/5 and [125I]NT‐3European Journal of Neuroscience, 1994
- 6-Hydroxydopamine lesions reduce BDNF mRNA levels in adult rat brain substantia nigraNeuroReport, 1994